Vivus

5 High-Impact Biotech Catalysts to Watch This Week
Seeking Alpha
Tue, 10/26/10 - 11:19 am
Arena Pharmaceuticals
Avanir
Biodel
EXACT Sciences
Vivus
VIVUS Shares Plunged: What You Need to Know
Motley Fool
Wed, 10/20/10 - 01:54 pm
Vivus
Qnexa
Vivus Sells MUSE to Meda
Yahoo/Zacks
Sun, 10/17/10 - 11:11 am
Vivus
Meda
Muse
erectile dysfunction
Update: Perfect FDA Drug Approval Pickers
TheStreet.com
Thu, 10/14/10 - 09:29 am
FDA
Hospira
Human Genome Sciences
Alexza
Jazz Pharmaceuticals
Alkermes
Arena Pharmaceuticals
Amylin
Vivus
Avanir
Forest Labs
Biodel
FDA's Top Q4 Blockbuster Drug Decisions
Fierce Biotech
Tue, 10/12/10 - 11:26 am
Linjeta
Biodel
Afrezza
MannKind
FDA
Benlysta
Human Genome
GSK
Bydureon
Eli Lilly
Amylin
Alkermes
Brilinta
AstraZeneca
Pradaxa
Boehringer Ingelheim
Qnexa
Vivus
Contrave
Orexigen
ipilimumab
Bristol-Myers Squibb
Merck KGaA
cladribine
Orexigen Shares Popped: What You Need to Know
Motley Fool
Thu, 10/7/10 - 06:04 pm
Orexigen
obesity
Arena Pharmaceuticals
Vivus
Why The FDA Keeps Rejecting Obesity Pills
Forbes
Mon, 10/4/10 - 05:19 pm
FDA
obesity
Arena Pharmaceuticals
Lorqess
Vivus
Qnexa
Vivus Races to Capture U.S. Approval of Obesity Drug
Seeking Alpha
Mon, 09/27/10 - 10:43 am
obesity
Vivus
Qnexa
Orexigen
Contrave
Arena Pharmaceuticals
Will the FDA Give Vivus More Time Before the Final Judgment on Qnexa?
Seeking Alpha
Sun, 09/26/10 - 12:22 pm
Qnexa
Vivus
obesity
Vivus Rallies on Positive Results for Obesity Drug
Seeking Alpha
Wed, 09/22/10 - 10:06 am
Vivus
obesity
Qnexa
Vivus: Weight Loss Extends Two Years
TheStreet.com
Tue, 09/21/10 - 12:07 pm
obesity
Vivus
Qnexa
Biotech Investor Calendar: Obesity Drugs
TheStreet.com
Tue, 09/21/10 - 12:10 pm
Vivus
Qnexa
Orexigen
obesity
Contrave
Arena Pharmaceuticals
Top 5 Upcoming FDA Decisions With Bullish Options Sentiment
Seeking Alpha
Sat, 09/18/10 - 11:07 am
Ista
Alexza
Biodel
Alkermes
Vivus
Speculative Bubble Growing Around Diet Drugs
BNET Pharma
Tue, 09/14/10 - 05:42 pm
Arena Pharmaceuticals
obesity
Takeda
Orexigen
Contrave
Abbott Laboratories
Meridia
Qnexa
Vivus
Arena Pharma Will Fail: Hedge Fund Poll
TheStreet.com
Fri, 09/10/10 - 09:32 am
Arena Pharmaceuticals
obesity
Vivus
Qnexa
Contrave
Orexigen
Arena's Lorcaserin: Weighed Down by Qnexa and Meridia
Seeking Alpha
Mon, 09/6/10 - 10:04 am
Arena Pharmaceuticals
obesity
lorcaserin
Qnexa
Meridia
Vivus
Arena Pharma: Understanding the Market for Anti-Obesity Drugs
Seeking Alpha
Fri, 09/3/10 - 11:57 am
Arena Pharmaceuticals
Contrave
Orexigen
Vivus
obesity
Qnexa
Volume Hunter: Diet Stocks Lift Biotech
Yahoo/IndieResearch
Thu, 09/2/10 - 04:01 pm
diet drugs
biotech
Arena Pharmaceuticals
Dendreon
Provenge
Exelixis
Vivus
Orexigen
Takeda
Contrave
Martek
21 Drugs Facing FDA Approval Decisions
TheStreet.com
Tue, 08/31/10 - 12:05 pm
FDA
Questcor Pharmaceuticals
Savient
Alkermes
Arena Pharmaceuticals
Roche
Novartis
Hospira
Human Genome
Alexza
Jazz Pharmaceuticals
Biodel
Amylin
Eli Lilly
Vivus
Avanir
Cadence Pharmaceuticals
Amgen
Cumberland
Orexigen
MannKind
Bristol-Myers Squibb
Vivus' Qnexa Panel Bodes Well for Arena's Obesity Drug
Seeking Alpha
Mon, 08/30/10 - 10:44 am
Qnexa
Vivus
advisory panels
Arena Pharmaceuticals
obesity

Pages